Theoretically, increased endothelin-1 may link endothelial dysfunction to no-reflow; however, clinical studies could not establish this relationship in ST-segment elevation myocardial infarction (STEMI) patients managed by the primary percutaneous intervention (PCI) [8]. Here, EDN1 is linked to endothelial dysfunction.